Form 8-K - Current report:
SEC Accession No. 0001640334-25-001570
Filing Date
2025-08-20
Accepted
2025-08-20 16:30:29
Documents
16
Period of Report
2025-08-19
Items
Item 1.02: Termination of a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K artl_8k.htm   iXBRL 8-K 33454
2 FORM OF TERMINATION AND MUTUAL RELEASE AGREEMENT artl_ex101.htm EX-10.1 35381
3 TERMINATION AGREEMENT artl_ex102.htm EX-10.2 20609
  Complete submission text file 0001640334-25-001570.txt   222279

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA artl-20250819.xsd EX-101.SCH 5022
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE artl-20250819_lab.xml EX-101.LAB 15188
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE artl-20250819_cal.xml EX-101.CAL 898
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE artl-20250819_pre.xml EX-101.PRE 9628
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE artl-20250819_def.xml EX-101.DEF 2099
18 EXTRACTED XBRL INSTANCE DOCUMENT artl_8k_htm.xml XML 4020
Mailing Address 505 LOMAS SANTA FE, SUITE 160 SOLANA BEACH CA 92075
Business Address 505 LOMAS SANTA FE, SUITE 160 SOLANA BEACH CA 92075 858-925-7049
ARTELO BIOSCIENCES, INC. (Filer) CIK: 0001621221 (see all company filings)

EIN.: 331220924 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38951 | Film No.: 251237203
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)